Table 2.
Case repots of methyldopa associated liver failure.
Case report | Maternal age (years) | GA at which methyldopa initiated (weeks) | GA at symptom onset (weeks) | Symptoms | Outcome |
---|---|---|---|---|---|
Picaud et al.5 *Abstract only | 22 | 33 | 3rd trimester | Initial symptoms of nausea, vomiting, and increased temperature; associated with febrile jaundice and coagulopathy in the third stage of labor. Patient passed away 3 days after delivery due to hematemesis, renal failure, and hepatic encephalopathy. | Maternal death 3 days after delivery |
Smith and Piercy6 | 30 | 10 | 13 | Jaundice, abdominal pain, nausea | Methyldopa discontinued at 14 weeks and re-introduced at 36 weeks’ gestation; C-section for family planning |
Thomas and Cardwell7 | 37 | 6 | 15 | Jaundice, dark urine | Complete resolution of symptoms at 21 weeks with discontinuation of medication |
Phadis et al.12 | 40 | 6 | 8 | Jaundice, dark urine, myalgia, fatigue, fever | Switched to labetalol and liver function gradually improved between 10 and24 weeks |
Ali et al.8 | 33 | 6 | 12 | Jaundice, dark urine | Resolved 2 weeks later with a course of prednisone |
Ozsvar et al.9 | 35 | 21 | 23 | Transaminitis | Switched to nifedipine; no information on outcome |
Slim et al.10 | 34 | 13 | 17 | Jaundice, pruritus, dark urine, pale stool | Liver function test results returned to normal levels within 5 weeks of discontinuation |
GA: gestational age.